Clinical Trial Update: Phase II Iressa + Irradiation Followed by Chemo in NSCLC [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase II trial evaluating Iressa (gefitinib) with irradiation followed by chemotherapy in non-small cell lung cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED